Database of Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

This is a retrospective and prospective study planned to include NSCLC patients with Leptomeningeal metastasis (LM) and treated with antitumor therapy after 2018, from multiple centers such as the First Affiliated Hospital of Guangzhou Medical University, Guangdong Sanjiu Brain Hospital, etc., aiming to establish a database related to the treatment strategies of LM patients, and to evaluate the efficacy (eg. Overall Survival/Time to Failure) and safety of different treatment strategies of LM patients, etc., as well as the significance of concomitant testing in LM patients.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• non-small cell lung cancer patients with Leptomeningeal metastases diagnosed after January 2018;

• Patients who underwent antitumor therapy after diagnosis of LM.

Locations
Other Locations
China
Guangdong Sanjiu Brain Hospital
RECRUITING
Guangzhou
the First Affiliated Hospital of Guangzhou Medical University
RECRUITING
Guangzhou
Contact Information
Primary
hong hai Yang
bjrf2009@yahoo.com
13711244230
Time Frame
Start Date: 2024-09-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 1000
Sponsors
Leads: Guangzhou Medical University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials